These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 25505955

  • 1. Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.
    Pender MP, Burrows SR.
    Clin Transl Immunology; 2014 Oct; 3(10):e27. PubMed ID: 25505955
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F.
    J Virol; 2019 Dec 15; 93(24):. PubMed ID: 31578295
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
    Pender MP, Csurhes PA, Smith C, Beagley L, Hooper KD, Raj M, Coulthard A, Burrows SR, Khanna R.
    Mult Scler; 2014 Oct 15; 20(11):1541-4. PubMed ID: 24493474
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
    Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R.
    JCI Insight; 2018 Nov 15; 3(22):. PubMed ID: 30429369
    [Abstract] [Full Text] [Related]

  • 5. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP, Mautner J, Mitterreiter JG, Hintzen RQ, Verjans GM.
    Mult Scler; 2016 Mar 15; 22(3):279-91. PubMed ID: 26041797
    [Abstract] [Full Text] [Related]

  • 6. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C, Hofmann J, Ruprecht K.
    Med Hypotheses; 2016 Jun 15; 91():109-113. PubMed ID: 27142157
    [Abstract] [Full Text] [Related]

  • 7. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
    Pender MP.
    Autoimmun Rev; 2009 Jun 15; 8(7):563-8. PubMed ID: 19254880
    [Abstract] [Full Text] [Related]

  • 8. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP.
    Neuroscientist; 2011 Aug 15; 17(4):351-67. PubMed ID: 21075971
    [Abstract] [Full Text] [Related]

  • 9. Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.
    Pender MP, Csurhes PA, Burrows JM, Burrows SR.
    Clin Transl Immunology; 2017 Jan 15; 6(1):e126. PubMed ID: 28197337
    [Abstract] [Full Text] [Related]

  • 10. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.
    Brain; 2008 Jul 15; 131(Pt 7):1712-21. PubMed ID: 18550621
    [Abstract] [Full Text] [Related]

  • 11. Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis.
    Hassani A, Reguraman N, Shehab S, Khan G.
    Front Immunol; 2021 Jul 15; 12():764937. PubMed ID: 34899715
    [Abstract] [Full Text] [Related]

  • 12. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y, Aïssi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D.
    Cytotherapy; 2014 Jan 15; 16(1):122-34. PubMed ID: 24094498
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.
    Veroni C, Serafini B, Rosicarelli B, Fagnani C, Aloisi F.
    J Neuroinflammation; 2018 Jan 16; 15(1):18. PubMed ID: 29338732
    [Abstract] [Full Text] [Related]

  • 14. Hypothesis: bipolar disorder is an Epstein-Barr virus-driven chronic autoimmune disease - implications for immunotherapy.
    Pender MP.
    Clin Transl Immunology; 2020 Apr 16; 9(4):e1116. PubMed ID: 32257210
    [Abstract] [Full Text] [Related]

  • 15. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses.
    Choi IK, Wang Z, Ke Q, Hong M, Qian Y, Zhao X, Liu Y, Kim HJ, Ritz J, Cantor H, Rajewsky K, Wucherpfennig KW, Zhang B.
    Proc Natl Acad Sci U S A; 2018 Jan 23; 115(4):E686-E695. PubMed ID: 29311309
    [Abstract] [Full Text] [Related]

  • 16. Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.
    Ioannides ZA, Csurhes PA, Douglas NL, Mackenroth G, Swayne A, Thompson KM, Hopkins TJ, Green KA, Blum S, Hooper KD, Wyssusek KH, Coulthard A, Pender MP.
    Front Neurol; 2021 Jan 23; 12():652811. PubMed ID: 33790852
    [Abstract] [Full Text] [Related]

  • 17. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
    Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlöhner S, Owens GP, Gilden D, Bennett JL.
    Neurology; 2010 Apr 06; 74(14):1127-35. PubMed ID: 20220124
    [Abstract] [Full Text] [Related]

  • 18. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
    Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F.
    J Exp Med; 2007 Nov 26; 204(12):2899-912. PubMed ID: 17984305
    [Abstract] [Full Text] [Related]

  • 19. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
    Pender MP.
    Autoimmune Dis; 2012 Nov 26; 2012():189096. PubMed ID: 22312480
    [Abstract] [Full Text] [Related]

  • 20. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J, Stuehler C, Egli A, Battegay M, Rauser G, Bantug GR, Brander C, Hess C, Khanna N.
    Cytotherapy; 2015 Sep 26; 17(9):1280-91. PubMed ID: 26276009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.